DiaMedica Therapeutics (DMAC) Change in Receivables (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Change in Receivables came in at $43000.0 in Q1 2026, up 152.94% year-on-year from $17000.0 in Q1 2025, and up 2250.0% quarter-over-quarter from -$2000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Change in Receivables (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Change in Receivables history runs 9 years deep, the most recent figure standing at $43000.0 for Q1 2026.
- On a quarterly basis, Change in Receivables rose 152.94% year-over-year to $43000.0 in Q1 2026; TTM through Mar 2026 was $48000.0, a 132.88% increase from a year earlier, with the FY2025 full-year figure at $22000.0, up 116.54% from the prior year.
- Change in Receivables grew to $43000.0 in Q1 2026 per DMAC's latest filing, from -$2000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $131000.0 in Q2 2023 and bottomed at -$101000.0 in Q3 2024.
- The 5-year median for Change in Receivables is $7000.0 (2022), against an average of $10058.8.
- Across the five-year window, Change in Receivables surged 1366.67% in 2022 and tumbled 1050.0% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $7000.0 in 2022, then jumped by 742.86% to $59000.0 in 2023, then slumped by 191.53% to -$54000.0 in 2024, then surged by 96.3% to -$2000.0 in 2025, then soared by 2250.0% to $43000.0 in 2026.
- Per Business Quant, the three latest DMAC Change in Receivables figures stand at $43000.0 (Q1 2026), -$2000.0 (Q4 2025), and $99000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - | 43,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,000.00 |
| Mar 31, 2026 | 43,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Jun 30, 2025 | -92,000.00 |
| Jun 30, 2025 | -92,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Mar 31, 2025 | 17,000.00 |
| Dec 31, 2024 | -54,000.00 |
| Dec 31, 2024 | -54,000.00 |
| Sep 30, 2024 | -101,000.00 |
| Sep 30, 2024 | -101,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -8,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Mar 31, 2024 | 30,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |